An article authored by Rob Sahr and Curtis Powell titled “Proposed March-In Guidance Signals Funding Agencies to Actively Evaluate Government Rights Under the Bayh-Dole Act” was published in Volume 16, Issue 1 of the International Pharmaceutical Industry Journal (IPI).
The Department of Commerce and the National Institute of Standards and Technology are now considering comments on their proposed new paradigm for the assessment of march-in rights, which has major implications for technologies developed using federal funding. In this article, Rob and Curtis discuss new agency considerations for exercising march-in rights, including the “reasonable price” of products.
READ THE FULL ARTICLE
Related podcast: